BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+22.87%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$830M
AUM Growth
+$830M
Cap. Flow
-$97.9M
Cap. Flow %
-11.8%
Top 10 Hldgs %
61.35%
Holding
46
New
10
Increased
9
Reduced
10
Closed
4

Top Buys

1
CYTK icon
Cytokinetics
CYTK
$36.5M
2
ARRY
Array Biopharma Inc
ARRY
$29.2M
3
SNDX icon
Syndax Pharmaceuticals
SNDX
$28.3M
4
OMED
OncoMed Pharmaceuticals, Inc.
OMED
$17.5M
5
ARQL
Arqule Inc
ARQL
$14.9M

Top Sells

1
ANAB icon
AnaptysBio
ANAB
$79M
2
CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
$45.9M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
$44.5M
4
CNCE
Concert Pharmaceuticals, Inc.
CNCE
$30.2M
5
CTMX icon
CytomX Therapeutics
CTMX
$23.4M

Sector Composition

1 Healthcare 85.77%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
$111M 13.4% 8,686,498 +2,283,973 +36% +$29.2M
ANAB icon
2
AnaptysBio
ANAB
$569M
$59.9M 7.22% 594,397 -784,737 -57% -$79M
BPMC
3
DELISTED
Blueprint Medicines
BPMC
$57.9M 6.98% 767,354 -240,000 -24% -$18.1M
XOMA icon
4
Xoma
XOMA
$392M
$53.5M 6.45% 1,502,800 – –
CNCE
5
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$51M 6.14% 1,969,789 -1,165,500 -37% -$30.2M
CYTK icon
6
Cytokinetics
CYTK
$4.23B
$46.6M 5.62% 5,721,888 +4,480,867 +361% +$36.5M
CCXI
7
DELISTED
ChemoCentryx, Inc.
CCXI
$45.1M 5.44% 7,587,416 – –
BLRX
8
BioLineRX
BLRX
$16.2M
$28.3M 3.42% 25,995,575 – –
SNDX icon
9
Syndax Pharmaceuticals
SNDX
$1.41B
$28.3M 3.41% +3,233,618 New +$28.3M
ARQL
10
DELISTED
Arqule Inc
ARQL
$27.1M 3.27% 16,436,912 +9,036,784 +122% +$14.9M
CTMX icon
11
CytomX Therapeutics
CTMX
$336M
$23.7M 2.86% 1,124,483 -1,106,415 -50% -$23.4M
CTIC
12
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$23M 2.78% 8,596,357 – –
KURA icon
13
Kura Oncology
KURA
$686M
$20.7M 2.5% 1,353,846 – –
INFI
14
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$19.8M 2.39% 9,766,508 +1,900,400 +24% +$3.86M
PVLA
15
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$19.8M 2.39% 2,623,562 -363,000 -12% -$2.74M
OMED
16
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$17.5M 2.11% +4,271,289 New +$17.5M
RGLS
17
DELISTED
Regulus Therapeutics
RGLS
$14.5M 1.75% 13,974,249 +1,025,020 +8% +$1.07M
ONCT
18
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$14.1M 1.7% 1,107,433 -1,000 -0.1% -$12.7K
PHXM
19
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$13.8M 1.66% +625,000 New +$13.8M
VBIV
20
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$13.2M 1.6% +3,100,000 New +$13.2M
FWP
21
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$12.6M 1.52% 3,455,117 +2,000,000 +137% +$7.32M
SPRO icon
22
Spero Therapeutics
SPRO
$116M
$12.1M 1.46% +1,029,185 New +$12.1M
CASC
23
DELISTED
Cascadian Therapeutics, Inc.
CASC
$11.6M 1.4% 3,133,224 – –
FSTX
24
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$11.1M 1.34% 823,474 +170,798 +26% +$2.3M
XENE icon
25
Xenon Pharmaceuticals
XENE
$2.98B
$10.1M 1.22% 3,588,830 – –
1
2